Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells.

Yang H, Wang Z, Capó-Aponte JE, Zhang F, Pan Z, Reinach PS.

Exp Eye Res. 2010 Sep;91(3):462-71. doi: 10.1016/j.exer.2010.06.022. Epub 2010 Jul 7.

2.

Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury.

Leedom AJ, Sullivan AB, Dong B, Lau D, Gronert K.

Am J Pathol. 2010 Jan;176(1):74-84. doi: 10.2353/ajpath.2010.090678. Epub 2009 Dec 11.

3.

Significance of lipid mediators in corneal injury and repair.

Kenchegowda S, Bazan HE.

J Lipid Res. 2010 May;51(5):879-91. doi: 10.1194/jlr.R001347. Epub 2009 Nov 3. Review.

4.

Dependence of EGF-induced increases in corneal epithelial proliferation and migration on GSK-3 inactivation.

Wang Z, Yang H, Zhang F, Pan Z, Capó-Aponte J, Reinach PS.

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4828-35. doi: 10.1167/iovs.08-2983. Epub 2009 May 14.

PMID:
19443725
5.

Wounding sheets of epithelial cells activates the epidermal growth factor receptor through distinct short- and long-range mechanisms.

Block ER, Klarlund JK.

Mol Biol Cell. 2008 Nov;19(11):4909-17. doi: 10.1091/mbc.E08-01-0097. Epub 2008 Sep 17.

6.

ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding.

Yin J, Yu FS.

Invest Ophthalmol Vis Sci. 2009 Jan;50(1):132-9. doi: 10.1167/iovs.08-2246. Epub 2008 Jul 24.

7.

Enantioselective effect of 12(S)-hydroxyeicosatetraenoic acid on 3T6 fibroblast growth through ERK 1/2 and p38 MAPK pathways and cyclin D1 activation.

Nieves D, Moreno JJ.

Biochem Pharmacol. 2008 Sep 1;76(5):654-61. doi: 10.1016/j.bcp.2008.06.013. Epub 2008 Jul 2.

PMID:
18640102
8.

Epidermal growth factor synergism with TGF-beta1 via PI-3 kinase activity in corneal keratocyte differentiation.

He J, Bazan HE.

Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2936-45. doi: 10.1167/iovs.07-0900.

9.
10.
11.
13.

Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells.

Wang Z, Yang H, Tachado SD, Capó-Aponte JE, Bildin VN, Koziel H, Reinach PS.

Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5267-75.

PMID:
17122112
14.
15.

Epithelial cell motility is triggered by activation of the EGF receptor through phosphatidic acid signaling.

Mazie AR, Spix JK, Block ER, Achebe HB, Klarlund JK.

J Cell Sci. 2006 Apr 15;119(Pt 8):1645-54. Epub 2006 Mar 28.

16.
17.

A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense.

Gronert K, Maheshwari N, Khan N, Hassan IR, Dunn M, Laniado Schwartzman M.

J Biol Chem. 2005 Apr 15;280(15):15267-78. Epub 2005 Feb 11.

19.

The rat leukocyte-type 12-lipoxygenase exhibits an intrinsic hepoxilin A3 synthase activity.

Nigam S, Patabhiraman S, Ciccoli R, Ishdorj G, Schwarz K, Petrucev B, Kühn H, Haeggström JZ.

J Biol Chem. 2004 Jul 9;279(28):29023-30. Epub 2004 May 3.

20.

Ocular immune privilege: therapeutic opportunities from an experiment of nature.

Streilein JW.

Nat Rev Immunol. 2003 Nov;3(11):879-89. Review. No abstract available.

PMID:
14668804

Supplemental Content

Support Center